ES2053196T3 - Metodo para la produccion de un radioinmunoconjugado. - Google Patents

Metodo para la produccion de un radioinmunoconjugado.

Info

Publication number
ES2053196T3
ES2053196T3 ES90909718T ES90909718T ES2053196T3 ES 2053196 T3 ES2053196 T3 ES 2053196T3 ES 90909718 T ES90909718 T ES 90909718T ES 90909718 T ES90909718 T ES 90909718T ES 2053196 T3 ES2053196 T3 ES 2053196T3
Authority
ES
Spain
Prior art keywords
compounds
production
radio
treatment
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90909718T
Other languages
English (en)
Inventor
Maurits Willem Geerlings
Franciscus Michael Kaspersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of ES2053196T3 publication Critical patent/ES2053196T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Abstract

LA INVENCION ACTUAL SE REFIERE A LA UTILIZACION DEL ACTINIO O DE UNO DE SUS FILIALES EN LA RADIOINMUNOTERAPIA. TAMBIEN SE PROPORCIONAN OTROS INMUNODERIVADOS QUE COMPRENDEN UN ISOTOPO, UN AGENTE SERVIDOR Y UN ANTICUERPO DE CONCENTRACION LENTA. LA INVENCION INCLUYE TAMBIEN, COMPUESTOS FARMACEUTICOS QUE COMPRENDEN DICHOS INMUNODERIVADOS, ASI COMO, OTROS COMPUESTOS QUE COMPRENDEN UNO O MAS AGENTES EXPULSORES. ESTOS COMPUESTOS EN CONSONANCIA CON LA INVENCION SON, PARTICULARMENTE, UTILES PARA EL TRATAMIENTO DE MICROMETASTASIS EN TERAPIAS COADYUVANTES, ASI COMO, PARA EL TRATAMIENTO DE TUMORES LOCALIZADOS.
ES90909718T 1989-06-19 1990-06-19 Metodo para la produccion de un radioinmunoconjugado. Expired - Lifetime ES2053196T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89201591 1989-06-19

Publications (1)

Publication Number Publication Date
ES2053196T3 true ES2053196T3 (es) 1994-07-16

Family

ID=8202415

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90909718T Expired - Lifetime ES2053196T3 (es) 1989-06-19 1990-06-19 Metodo para la produccion de un radioinmunoconjugado.

Country Status (11)

Country Link
US (1) US5246691C1 (es)
EP (1) EP0429624B1 (es)
JP (1) JPH089553B2 (es)
KR (1) KR0179645B1 (es)
AU (1) AU629367B2 (es)
CA (1) CA2034484C (es)
DE (1) DE69007430T2 (es)
DK (1) DK0429624T3 (es)
ES (1) ES2053196T3 (es)
FI (1) FI98707C (es)
WO (1) WO1990015625A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403771B1 (en) * 1991-02-19 2002-06-11 Actinium Pharmaceuticals, Limited Method and means for site directed therapy
CA2100709C (en) * 1992-07-27 2004-03-16 Maurits W. Geerlings Method and means for site directed therapy
EP0746761A4 (en) * 1993-03-12 1997-02-26 Akzo America Inc PROCESS FOR EXTRACTING RADON 220 FROM A MIXTURE OF RADIOACTIVE ISOTOPES
LU88636A1 (de) * 1995-07-03 1997-01-03 Euratom Verfahren zur Erzeugung von Actinium-225
LU88637A1 (de) * 1995-07-03 1997-01-03 Euratom Verfahren zur Erzeugung von Actinium-225 und Wismut-213 durch Bestrahlung von Radium-226 mit hochenergetischen Gammaquanten
EP0842668B1 (en) * 1996-11-15 2002-09-04 European Atomic Energy Community (Euratom) Ex-corpore method for treating human blood cells
US5809394A (en) * 1996-12-13 1998-09-15 Battelle Memorial Institute Methods of separating short half-life radionuclides from a mixture of radionuclides
US6117413A (en) * 1997-11-12 2000-09-12 Battelle Memorial Institute Radionuclide-binding compound, a radionuclide delivery system, a method of making a radium complexing compound, a method of extracting a radionuclide, and a method of delivering a radionuclide
JP2002509122A (ja) * 1998-01-16 2002-03-26 エムセーアー ディベロップメント ベー．フェー． 癌および自己免疫疾患のための治療における放射性標識化モノクローナルＩｇＭの使用
DE19911329A1 (de) * 1998-03-27 2000-09-21 Benes Ivan Friedrich Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung
US6696551B1 (en) * 1999-03-23 2004-02-24 The United States Of America As Represented By The Department Of Health And Human Services 225Ac-HEHA and related compounds, methods of synthesis and methods of use
AU7548901A (en) * 2000-06-16 2002-01-02 Sloan Kettering Inst Cancer Liposomal encapsulation of chelated actinium-225 and uses thereof
US6852296B2 (en) * 2001-06-22 2005-02-08 Pg Research Foundation Production of ultrapure bismuth-213 for use in therapeutic nuclear medicine
US7087206B2 (en) * 2002-04-12 2006-08-08 Pg Research Foundation Multicolumn selectivity inversion generator for production of high purity actinium for use in therapeutic nuclear medicine
US20030086868A1 (en) * 2002-08-12 2003-05-08 Dangshe Ma Actinium-225 complexes and conjugates for radioimmunotherapy
WO2004062722A2 (en) * 2003-01-08 2004-07-29 Sloan Kettering Institute For Cancer Research Prevention of systemic toxicity during radioimmunotherapy for intravascularly disseminated cancers
EA008195B1 (ru) * 2003-04-15 2007-04-27 Алгета Ас Применение тория-227 в лучевой терапии заболеваний мягких тканей
DE102004022200B4 (de) * 2004-05-05 2006-07-20 Actinium Pharmaceuticals, Inc. Radium-Target sowie Verfahren zu seiner Herstellung
US7618627B2 (en) 2004-06-03 2009-11-17 The Regents Of The University Of California Method of increasing radiation sensitivity by inhibition of beta one integrin
US7736610B2 (en) * 2004-09-24 2010-06-15 Battelle Energy Alliance, Llc Actinium radioisotope products of enhanced purity
US7157061B2 (en) * 2004-09-24 2007-01-02 Battelle Energy Alliance, Llc Process for radioisotope recovery and system for implementing same
DE102006008023B4 (de) * 2006-02-21 2008-05-29 Actinium Pharmaceuticals, Inc. Verfahren zum Reinigen von 225Ac aus bestrahlten 226Ra-Targets
EP2082071B1 (en) * 2006-09-08 2014-06-25 Actinium Pharmaceuticals Inc. Method for the purification of radium from different sources
RU2565402C2 (ru) 2009-07-22 2015-10-20 Актиниум Фармасьютикалз Инк. Способы получения радиоиммуноконъюгатов
GB201002508D0 (en) 2010-02-12 2010-03-31 Algeta As Product
US20150157742A1 (en) * 2013-12-11 2015-06-11 The European Atomic Energy Community (Euratom), Represented By The European Commission SYNTHESIS OF BIOLOGICAL COMPOUNDS LABELED WITH THE ALPHA EMITTER Ac-225
EP3409297A1 (en) 2017-05-30 2018-12-05 AlfaRim Medial Holding B.V. The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy
US20200230266A1 (en) 2017-09-20 2020-07-23 Alfarim Medical Holding B.V. The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4828991A (en) * 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
NO881077L (no) * 1987-03-11 1988-09-12 Univ Michigan Kjemo-radio-immuno-konjugater.
US4923985A (en) * 1988-05-25 1990-05-08 The United States Of America As Represented By The Department Of Health & Human Services Process for synthesizing macrocyclic chelates

Also Published As

Publication number Publication date
DE69007430T2 (de) 1994-07-07
AU629367B2 (en) 1992-10-01
DE69007430D1 (de) 1994-04-21
JPH089553B2 (ja) 1996-01-31
KR0179645B1 (en) 1999-03-20
FI910772A0 (fi) 1991-02-18
EP0429624A1 (en) 1991-06-05
JPH04500366A (ja) 1992-01-23
EP0429624B1 (en) 1994-03-16
DK0429624T3 (da) 1994-05-30
AU5857490A (en) 1991-01-08
US5246691A (en) 1993-09-21
US5246691C1 (en) 2001-10-09
FI98707C (fi) 1997-08-11
CA2034484A1 (en) 1990-12-20
WO1990015625A1 (en) 1990-12-27
KR920700690A (ko) 1992-08-10
FI98707B (fi) 1997-04-30
CA2034484C (en) 2000-08-15

Similar Documents

Publication Publication Date Title
ES2053196T3 (es) Metodo para la produccion de un radioinmunoconjugado.
ES2055745T3 (es) Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes.
ES2045110T3 (es) Mejoras en o relacionadas con antagonistas de leucotrienos.
GT199800037A (es) Combinaciones para diabetes de sulfonilurea - glitazona.
ES2137372T3 (es) Solucion antifungica para las uñas.
BR0115087A (pt) Membro radioativo para uso em braquiterapia e métodos de fazer um membro radioativo e de tratar uma condição que responda a terapia por radiação
ZA715368B (en) Method of manufacture of devices for emitting vapours of active volatile agents
DE3584174D1 (de) Rheumamittel.
SE8402098L (sv) Perfluorkarbonemulsion, framstellning derav samt dess anvendning i terapi
ES2051733T3 (es) Procedimiento de obtencion de un medicamento a base de tamoxifen para uso local.
DE3887151D1 (de) Inhibitoren für zellenzuwachs und methoden für krebsbehandlung.
ES2082831T3 (es) Composicion para tratamiento de tejidos con propiedades suavizantes.
FR1315251A (fr) Porte coulissante et basculante, plus particulièrement destinée aux véhicules
ES503650A0 (es) Procedimiento para la trimetilsililacion de compuestos organicos que llevan uno o mas atomo de hidrogeno activo.
ES527893A0 (es) Procedimiento de obtencion de un agente para el tratamiento de acero fundido
IT1072710B (it) Dispositivo per la produzione di gabbiette di sicurezza per tappi di bottiglie di vini spumanti o simili
ATE2049T1 (de) Mittel zur therapie von immunkomplexerkrankungen.
ES2042493T3 (es) Nuevos derivados de antraciclina, sus usos como agente antitumoral y la produccion de los mismos.
ES2081879T3 (es) Reduccion de la acidez de poliesteres mediante reaccion en fundido obturando con enamidas o bases schiff.
ATA9076A (de) Fuhrung fur schiebeturen von mobeln, insbesondere schranken
ES2038663T3 (es) Un metodo para preparar una composicion para la aplicacion por via topica, destinada al tratamiento de la enfermedad epitelial hiperproliferativa.
ES2013687T3 (es) Procedimiento y agente para la conservacion de la piedra.
ES2008097B3 (es) - 2-sustitutivo 4, 4, 7, 7-tetrametil-1,3dioxacicloheptano, su fabricacion y utilizacion como sustancia aromatica
DK104030C (da) Middel til bekæmpelse af skadelige organismer og fremgangsmåde til fremstilling af phosphinylimider til anvendelse heri.
AT250258B (de) Verfahren zur Herstellung von vorgespannten Verankerungen für Bauwerke, wie Stützmauern, Baugrubensicherungen u. dgl. und nach diesem Verfahren hergestellter Vorspannanker

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 429624

Country of ref document: ES